SPDR S&P Pharmaceuticals ETF
XPH
XPH
80 hedge funds and large institutions have $143M invested in SPDR S&P Pharmaceuticals ETF in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 5 closing their positions.
Holders
80
Holders Change
+8
Holders Change %
+11.11%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
15
Reduced
26
Closed
5
Calls
$2.29M
Puts
–
Net Calls
+$2.29M
Net Calls Change
+$85K
Top Buyers
1 |
FMI
1
Factory Mutual Insurance
Waltham,
Massachusetts
|
$10.9M |
2 |
2
Goldman Sachs
New York
|
$32.5M |
3 |
3
Morgan Stanley
New York
|
$25.9M |
4 |
KAS
4
Kestra Advisory Services
Austin,
Texas
|
$1.54M |
5 |
PAG
5
Private Advisor Group
Morristown,
New Jersey
|
$1.44M |